Suppr超能文献

结核性脑膜炎对视交叉结核瘤相关矛盾性视力丧失:8 例报告。

Paradoxical vision loss associated with optochiasmatic tuberculoma in tuberculous meningitis: a report of 8 patients.

机构信息

Department of Neurology Chhatrapati Shahuji Maharaj Medical University, Uttar Pradesh, Lucknow, India.

出版信息

J Infect. 2010 Jun;60(6):458-66. doi: 10.1016/j.jinf.2010.03.013. Epub 2010 Mar 25.

Abstract

BACKGROUND

Paradoxical appearance of new or expansion of existing optochiasmatic tuberculoma, leading to severe vision loss, is a devastating complication in patient with tuberculous meningitis.

METHODS

We report a series of 8 cases of tuberculous meningitis that developed paradoxical vision loss associated with optochiasmatic tuberculoma. Clinical assessment and magnetic resonance imaging (MRI) done at presentation, at the time of deterioration, and at 9 months were analyzed.

RESULTS

All patients had good vision acuity and normal visual field at baseline. None of them had optochiasmatic tuberculoma on magnetic resonance imaging at baseline, though 3 patients had optochiasmatic arachnoiditis. The mean interval of onset of paradoxical optochiasmatic tuberculoma was 41 days after starting antituberculosis therapy. Paradoxical optochiasmatic tuberculoma was associated with vision deterioration in all patients, 6 of whom developed severe vision loss (vision acuity <or=6/60). Repeat neuroimaging showed new optochiasmatic tuberculoma in all patients. All patients were treated with extended course of dexamethasone for 6 weeks along with antituberculosis therapy. Two patients died at 62 and 211 days respectively. Repeat neuroimaging in rest of the patients showed resolution of optochiasmatic tuberculoma. At 9 months follow-up, vision improved completely in 3 patients and partially in 3 patients.

CONCLUSION

Prompt recognition of paradoxical optochiasmatic tuberculoma with the help of vision assessment and neuroimaging is vital for patient's life and vision. Paradoxical reactions should not be labeled as a new or resistant infection. The prior treatment schedule should continue, and dexamethasone may be added or its dose enhanced.

摘要

背景

结核性脑膜炎患者新出现或原有视神经-下丘脑结核瘤扩大,导致严重视力丧失,这是一种破坏性并发症。

方法

我们报告了 8 例结核性脑膜炎患者,这些患者发生了与视神经-下丘脑结核瘤相关的反常视力丧失。对发病时、恶化时和 9 个月时的临床评估和磁共振成像(MRI)进行了分析。

结果

所有患者基线视力均良好,视野正常。基线 MRI 均未见视神经-下丘脑结核瘤,尽管 3 例存在视神经-下丘脑蛛网膜炎。反常性视神经-下丘脑结核瘤发病的平均间隔为抗结核治疗开始后 41 天。反常性视神经-下丘脑结核瘤与所有患者的视力恶化有关,其中 6 例视力严重下降(视力<或=6/60)。重复神经影像学检查显示所有患者均出现新的视神经-下丘脑结核瘤。所有患者均接受了 6 周的地塞米松延长疗程治疗,同时接受抗结核治疗。2 例患者分别在第 62 天和第 211 天死亡。其余患者的重复神经影像学检查显示视神经-下丘脑结核瘤已消退。在 9 个月的随访中,3 例患者视力完全恢复,3 例患者部分恢复。

结论

借助视力评估和神经影像学检查及时识别反常性视神经-下丘脑结核瘤对患者的生命和视力至关重要。反常反应不应被标记为新的或耐药感染。应继续原有的治疗方案,并可加用地塞米松或增加其剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验